Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Gastroenterology

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.gastro.2012.06.035PMID 22750463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT

  2011cited by this paper
• Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan

  2011cited by this paper
• Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.

  2010cited by this paper
• Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk

  2010cited by this paper
• Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma.

  2010cited by this paper
• Metachronous gastric cancer following complete remission of gastric MALT lymphoma.

  2009cited by this paper
• Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type.

  2009cited by this paper
• Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial

  2009cited by this paper
• Second primary cancers: an overview.

  2008cited by this paper
• IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

  2008cited by this paper
• Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study.

  2008cited by this paper
• Helicobacter pylori: host genetics and disease outcomes

  2008cited by this paper
• Secondary malignancies after treatment for indolent non-Hodgkin’s lymphoma: a 16-year follow-up study

  2008cited by this paper
• Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations.

  2006cited by this paper
• Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.

  2006cited by this paper
• Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: Results of a 196-patient series

  2006cited by this paper
• Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.

  2005cited by this paper
• Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?

  2005cited by this paper
• Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study.

  2005cited by this paper
• Gastric MALT Lymphomas Are Divided Into Three Groups Based on Responsiveness to Helicobacter Pylori Eradication and Detection of API2-MALT1 Fusion

  2004cited by this paper
• Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.

  2004cited by this paper
• IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection.

  2004cited by this paper
• Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

  2003cited by this paper
• Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma.

  2003cited by this paper
• Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series

  2003cited by this paper
• Remarkable resemblance in the mode of transmission of HCV infection among haemodialysis patients and IVDAs

  2003cited by this paper
• Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

  2003cited by this paper
• Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways.

  2002cited by this paper
• T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication.

  2001cited by this paper
• Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.

  1999cited by this paper
• Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population.

  1999cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper
• Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.

  1997cited by this paper
• Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.

  1996cited by this paper
• Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.

  1995cited by this paper
• High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma.

  1995cited by this paper
• Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis.

  1992cited by this paper

• Lymphomes gastro-intestinaux

  2026cites this paper
• Lymphomes gastro-intestinaux

  2025cites this paper
• Lymphomes gastro-intestinaux

  2025cites this paper
• Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025

  2025cites this paper
• Impact of Helicobacter pylori Antibiotic Resistance on Treatment Outcomes in Gastrointestinal Lymphomas: A Meta-Analysis.

  2025cites this paper
• Advances in the Pathogenesis, Diagnosis, Treatment, and Prognosis of Marginal Zone Lymphoma

  2025cites this paper
• Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)

  2024cites this paper
• Mukosaassoziierte Lymphome des Gastrointestinaltrakts

  2024cites this paper
• Mukosaassoziierte Lymphome des Gastrointestinaltrakts

  2024cites this paper
• Should All Patients With Stage IE Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Receive Antibiotic Eradication Therapy for Helicobacter pylori?

  2024cites this paper
• Leukämien im Fokus – Meilensteine und aktuelle Herausforderungen

  2024cites this paper
• Mukosaassoziierte Lymphome des Gastrointestinaltrakts

  2024cites this paper
• Next-Generation-Sequencing of the Human B-Cell Receptor Improves Detection and Diagnosis and Enhances Disease Monitoring in Patients with Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

  2024cites this paper
• Effectiveness of Helicobacter pylori eradication in the treatment of early-stage gastric mucosa-associated lymphoid tissue lymphoma: An up-to-date meta-analysis

  2023cites this paper
• Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma

  2023cites this paper
• Clinical Management of Patients with Gastric MALT Lymphoma: A Gastroenterologist’s Point of View

  2023cites this paper
• Impact of helicobacter pylori on human physiology and digestive disorders

  2022cites this paper
• Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001

  2022cites this paper
• Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research

  2022cites this paper
• Rituximab or rituximab plus chlorambucil for translocation (11;18)-negative gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomized observational study

  2022cites this paper
• Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations

  2022cites this paper
• Gastric MALT Lymphoma: A 8-Year Experience

  2021cites this paper
• HomA and HomB, outer membrane proteins of Helicobacter pylori down-regulate activation-induced cytidine deaminase (AID) and Ig switch germline transcription and thereby affect class switch recombination (CSR) of Ig genes in human B-cells.

  2021cites this paper
• Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1‐mediated DNA methylation mechanism

  2020cites this paper
• 3 ungewöhnliche Verläufe von gastrointestinalen MALT-Lymphomen

  2020influential citation
• Integrating Conflicting Cancer Theories by Recognizing the Roles of Epigenetic and Genetic Alterations in the Immediate-Cancer-Causing Genes that Establish Cellular Immortality and Autonomy

  2020cites this paper
• 3 ungewöhnliche Verläufe von gastrointestinalen MALT-Lymphomen

  2020cites this paper
• Helicobacter pylori Infection: When Should It Be Treated?

  2020cites this paper
• Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology

  2020cites this paper
• Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2020cites this paper
• An Updated Approach to Evaluation and Treatment of Helicobacter pylori Infection

  2019cites this paper
• Frontline antibiotic therapy for early‐stage Helicobacter pylori‐negative gastric MALT lymphoma

  2019cites this paper
• Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy

  2019cites this paper
• Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up

  2019cites this paper
• NK-18, a promising antimicrobial peptide: anti-multidrug resistant leukemia cells and LPS neutralizing properties.

  2018cites this paper
• The fourth Mexican consensus on Helicobacter pylori.

  2018cites this paper
• Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial

  2018cites this paper
• The fourth Mexican consensus on Helicobacter pylori

  2018cites this paper
• Laparoscopic Sleeve Gastrectomy - An Unexpected Finding: MALT Lymphoma in a H.Pylori-Negative Patient

  2017cites this paper
• Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.

  2017cites this paper
• Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma

  2017cites this paper
• A case of API2-MALT1-positive gastric MALT lymphoma with concomitant diffuse large B-cell lymphoma

  2017cites this paper
• Host pathogen interactions in Helicobacter pylori related gastric cancer

  2017cites this paper
• ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

  2017cites this paper
• Clinical aspects and therapy of gastrointestinal MALT lymphoma.

  2017cites this paper
• Gastric Extranodal Marginal Zone B-Cell Lymphoma of MALT

  2016cites this paper
• The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance.

  2016cites this paper
• Gastric malt lymphoma: Analysis of a series of consecutive patients over 20 years

  2016cites this paper
• [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease].

  2016cites this paper
• A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma

  2016cites this paper
• Dual effect of LPS on murine myeloid leukemia cells: Pro-proliferation and anti-proliferation.

  2016cites this paper
• S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease

  2016cites this paper
• Management of the marginal zone lymphomas.

  2015cites this paper
• Pro-Inflammatory Cytokine IL-1β Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma

  2015cites this paper
• Primary extranodal B-cell lymphoma: current concepts and treatment strategies.

  2015cites this paper
• The Role of Infectious Agents, Antibiotics, and Antiviral Therapy in the Treatment of Extranodal Marginal Zone Lymphoma and Other Low-Grade Lymphomas

  2015cites this paper
• Helicobacter pylori-induced gastric inflammation and gastric cancer.

  2014cites this paper
• Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis

  2014cites this paper
• Helicobacter pylori and upper gastrointestinal diseases: A review

  2014cites this paper
• Helicobacter pylori infection: new pathogenetic and clinical aspects.

  2014cites this paper
• At the Bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer

  2014cites this paper
• The origin and targeting of mucosa-associated lymphoid tissue lymphomas

  2014cites this paper
• Gastric MALT lymphoma - update on diagnosis and treatment.

  2014cites this paper
• Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

  2014cites this paper
• Secondary mucosa-associated lymphoid tissue (MALT) lymphoma of the colon

  2013cites this paper
• Role of Helicobacter pylori virulence factor cytotoxin-associated gene A in gastric mucosa-associated lymphoid tissue lymphoma.

  2013cites this paper
• Gastric mucosal-associated lymphoid tissue lymphoma.

  2013cites this paper
• Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2010cites this paper
• arriba »PPI absetzen« Modul-Beschreibung

  year unknowncites this paper
• World Journal of Gastroenterology

  year unknowncites this paper
• ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

  year unknowncites this paper